MA
Veradermics, Incorporated
MANE · NYSE
$106.64 -1.88% (-$2.04)
1M +8.42%
Piotroski F-Score Weak
3/9Valuation
-
N/A P/E N/A
PEG N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
-
N/A ROIC N/A
Asset turnover N/A
ROE N/A
Debt
-
N/A Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio N/A
Stability
59 /100
Moderate Beta 1.23x
Rev. volatility N/A
Profitable years N/A
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na MANE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Reid Waldman
Employees
37
Headquarters
New Haven
Nadcházející události
10 LIS
Earnings
Upcoming earnings report